Lead optimization of dopamine D3 receptor antagonist for substance use disorder (SUD).
Ended Awarded Last action
- Contract number
- 75N95021F00001
- Awardee
-
Regents Of The University Of Minnesota UEI KABJZBBJ4B54
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,259,577
Award facts
- Opportunity
-
- N01TR19200703 Solicitation number
- Contract value 47% obligated
-
- $1,259,577.32 Current, with exercised options
- $2,654,934.32 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Minneapolis, MN 55455, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$135,780 | |
| Terminate for Convenience | $0 | |
| Original award | $1,395,357 |
About this award
The National Institute on Drug Abuse issued a delivery order to the Regents of the University of Minnesota on September 26, 2021, with a ceiling value of $2.65 million, for lead optimization of a dopamine D3 receptor antagonist to support substance use disorder research. The order is issued under the CRO Support for NCATS Medicinal Chemistry for Lead Optimization parent vehicle and carries cost-no-fee pricing with an ultimate completion date of September 25, 2022.
Place of performance is Minneapolis, MN. In fiscal year 2022, the University of Minnesota invoiced $1 million against the order, deploying 4.5 FTEs across 9,357 contractor hours at a derived government-paid rate of $110.85 per hour. The university self-performed all reported work with no subcontractors.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to Regents Of The University Of Minnesota by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $1,259,577 on 75N95021F00001. Its potential value, with all options, is $2,654,934.
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under 75N95019D00031, an indefinite delivery contract, on CRO Support for NCATS Medicinal Chemistry for Lead Optimization.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award